JP2025506681A5 - - Google Patents
Info
- Publication number
- JP2025506681A5 JP2025506681A5 JP2024548391A JP2024548391A JP2025506681A5 JP 2025506681 A5 JP2025506681 A5 JP 2025506681A5 JP 2024548391 A JP2024548391 A JP 2024548391A JP 2024548391 A JP2024548391 A JP 2024548391A JP 2025506681 A5 JP2025506681 A5 JP 2025506681A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310865P | 2022-02-16 | 2022-02-16 | |
| US63/310,865 | 2022-02-16 | ||
| US202263316705P | 2022-03-04 | 2022-03-04 | |
| US63/316,705 | 2022-03-04 | ||
| PCT/US2023/062531 WO2023158990A1 (en) | 2022-02-16 | 2023-02-14 | Method of reducing cst fluctuation in neovascular amd by a recombinant adeno-associated virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025506681A JP2025506681A (ja) | 2025-03-13 |
| JP2025506681A5 true JP2025506681A5 (https=) | 2026-02-24 |
| JPWO2023158990A5 JPWO2023158990A5 (https=) | 2026-02-24 |
Family
ID=85570182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548391A Pending JP2025506681A (ja) | 2022-02-16 | 2023-02-14 | 組み換えアデノ随伴ウイルスによる血管新生ａｍｄにおけるｃｓｔ変動の低減方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP4479098A1 (https=) |
| JP (1) | JP2025506681A (https=) |
| KR (1) | KR20240161978A (https=) |
| AU (1) | AU2023221321A1 (https=) |
| CA (1) | CA3244250A1 (https=) |
| IL (1) | IL314762A (https=) |
| MX (1) | MX2024010002A (https=) |
| WO (1) | WO2023158990A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20171334T1 (hr) | 2011-04-22 | 2017-11-17 | The Regents Of The University Of California | Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe |
| CN110546257B (zh) | 2017-03-17 | 2024-03-01 | 阿德夫拉姆生物技术股份有限公司 | 用于增强基因表达的组合物和方法 |
| FI4027983T3 (fi) * | 2019-09-11 | 2026-02-03 | Adverum Biotechnologies Inc | Silmän neovaskulaaristen sairauksien hoito afliberseptiä koodaavilla aav2-varianteilla |
| WO2021050094A1 (en) * | 2019-09-11 | 2021-03-18 | Adverum Biotechnologies, Inc. | Methods of treating ocular neovascular diseases using aav2 variants encoding aflibercept |
-
2023
- 2023-02-14 EP EP23710626.5A patent/EP4479098A1/en not_active Withdrawn
- 2023-02-14 AU AU2023221321A patent/AU2023221321A1/en active Pending
- 2023-02-14 WO PCT/US2023/062531 patent/WO2023158990A1/en not_active Ceased
- 2023-02-14 IL IL314762A patent/IL314762A/en unknown
- 2023-02-14 CA CA3244250A patent/CA3244250A1/en active Pending
- 2023-02-14 KR KR1020247030971A patent/KR20240161978A/ko active Pending
- 2023-02-14 EP EP25188887.1A patent/EP4682163A3/en active Pending
- 2023-02-14 JP JP2024548391A patent/JP2025506681A/ja active Pending
-
2024
- 2024-08-15 MX MX2024010002A patent/MX2024010002A/es unknown